Fundz

Renibus Therapeutics, Inc. reported raising $111 Million in an initial SEC Form D filing, from an offering of $300,000

PRIVATEFeb 23, 2016

Amount Raised

$111 Million

$111 Million sold, per SEC Form D (first sale Feb 23, 2016)

Round Type

Venture

SouthlakeBiotechnologyHealthcareHealth CareMedicalTherapeuticsBiopharma

Quick answer

Renibus Therapeutics raised $111 Million in a funding round, dated February 23, 2016. Renibus Therapeutics is based in Southlake, Texas, United States.

How much did Renibus Therapeutics raise?
Renibus Therapeutics raised $111 Million in a funding round on February 23, 2016.
What does Renibus Therapeutics do?
Renibus is a clinical-stage biopharmaceutical company focused on preventing disease progression, protecting against organ damage, and improving outcomes in cardiorenal diseases.
Where is Renibus Therapeutics based and how big is it?
Renibus Therapeutics is based in Southlake, Texas, United States. Fundz records about 332 employees.
Who are the decision-makers at Renibus Therapeutics?
Fundz holds 1 contact at Renibus Therapeutics, including the Co-Founder, President and COO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Medical around the same time

Companies in the same sectors as Renibus Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Monopar Therapeutics raised an undisclosed amount on March 15, 2016.
  • Apellis Pharmaceuticals raised $47M on February 8, 2016.
  • Cocrystal Pharma, Inc. raised $5M on March 30, 2016.
  • Acutus Medical raised $75M on March 28, 2016.
  • Kodiak Sciences raised $34M on March 24, 2016.
  • Minerva Neurosciences raised $1M (Seed) on March 18, 2016.

Who to call at Renibus Therapeutics, and when

A new round usually means Renibus Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Renibus Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Renibus Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Renibus Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Renibus Therapeutics

Location

Southlake, Texas, United States

About

Renibus is a clinical-stage biopharmaceutical company focused on preventing disease progression, protecting against organ damage, and improving outcomes in cardiorenal diseases. Its pipeline includes first-in-class therapies that activate cytoprotective pathways. Lead candidate RBT-1, currently in Phase 2 for cardiac surgery, will enter Phase 3 trials to reduce complications post-cardiothoracic surgery. Other programs include RBT-2 for slowing CKD progression, RBT-3 for preventing cisplatin-induced nephrotoxicity, and RBT-9, an anti-inflammatory compound that showed promise in reducing hospital stays in COVID-19 patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Renibus Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJeff K., Co-Founder, President and COOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Renibus Therapeutics's next move

See what Strategic adds

Renibus Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.